Clinical Trial Update: Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating the safety and efficacy of LX111 gene therapy in patients with diabetic macular edema. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• LX111 Gene Therapy (LX111)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Diabetic Macular Edema (DME) | EARLY_Phase 1 | Status: RECRUITING